Skip to main content
MB

Materialize Bio

Materialize Bio provides a 3D manufacturing platform that transforms natural biopolymers—such as silk, collagen, chitosan, and alginate—into complex, pure‑material medical components. By enabling precise shaping of these biopolymers, the platform supports a wide range of medical and surgical innovations, from implantable devices to tissue scaffolds. The company’s focus on natural biomaterials aims to improve biocompatibility and performance in advanced healthcare applications.

Somerville, United StatesFounded 20234300+ followers
Updated 14 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current medical device manufacturing relies heavily on synthetic polymers and complex processing steps, limiting the use of fully biodegradable, natural materials and restricting the creation of patient‑specific implants with optimal biocompatibility.

Solution

Materialize Bio offers a 3D additive manufacturing platform that processes natural biopolymers—silk, collagen, chitosan, and alginate—into complex, pure‑material structures. The system integrates material preparation, precise extrusion, and post‑processing workflows to produce implants and surgical tools without synthetic additives. By enabling direct printing of these biodegradable polymers, the platform supports a wide range of therapeutic applications, from tissue scaffolds to custom orthopedic components. Clinicians and developers can design patient‑specific geometries using standard CAD tools, then fabricate them on‑site or in a regulated facility, reducing supply chain complexity and improving clinical outcomes.

Target Audience

Primary customers are medical device manufacturers, biotech firms, and surgical teams seeking to produce patient‑specific, fully biodegradable implants and tools.

Features

  • Multi‑material extrusion head calibrated for high‑viscosity natural polymers
  • Closed‑loop temperature and humidity control to preserve biopolymer integrity during printing
  • Integrated sterilization module compatible with FDA‑compliant cleanroom environments
  • Software suite that converts medical imaging data into printable STL files with support for lattice and gradient structures
  • Material library with validated mechanical and degradation profiles for silk, collagen, chitosan, and alginate
  • Quality‑assurance analytics that monitor layer adhesion, porosity, and dimensional accuracy in real time
This profile is AI-generated and may contain inaccuracies.